These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 36169086)
1. Effect of intravenous pulses of methylprednisolone 250 mg versus dexamethasone 6 mg in hospitalised adults with severe COVID-19 pneumonia: An open-label randomised trial. Corral-Gudino L; Cusacovich I; Martín-González JI; Muela-Molinero A; Abadía-Otero J; González-Fuentes R; Ruíz-de-Temiño Á; Tapia-Moral E; Cuadrado-Medina F; Martín-Asenjo M; Miramontes-González P; Delgado-González JL; Ines S; Abad-Manteca L; Usategui-Martín I; Ruiz-Albi T; Miranda-Riaño S; Rodríguez-Fortúnez P; Rodríguez-Jiménez C; López-Franco E; Marcos M; Eur J Clin Invest; 2023 Jan; 53(1):e13881. PubMed ID: 36169086 [TBL] [Abstract][Full Text] [Related]
2. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial. Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M; Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568 [TBL] [Abstract][Full Text] [Related]
3. Treatment of COVID-19 pneumonia with glucocorticoids (CORTIVID): a structured summary of a study protocol for a randomised controlled trial. Les Bujanda I; Loureiro-Amigo J; Bastons FC; Guerra IE; Sánchez JA; Murgadella-Sancho A; Rey RG; López JL; Álvarez JS Trials; 2021 Jan; 22(1):43. PubMed ID: 33430891 [TBL] [Abstract][Full Text] [Related]
4. Prolonged higher dose methylprednisolone Salton F; Confalonieri P; Centanni S; Mondoni M; Petrosillo N; Bonfanti P; Lapadula G; Lacedonia D; Voza A; Carpenè N; Montico M; Reccardini N; Meduri GU; Ruaro B; ; Confalonieri M; ; Citton GM; Lapadula G; Bozzi C; Tavano S; Pozzan R; Andrisano AG; Jaber M; Mari M; Trotta L; Mondini L; Barbieri M; Ruggero L; Antonaglia C; Soave S; Torregiani C; Bogatec T; Baccelli A; Nalesso G; Re B; Pavesi S; Barbaro MPF; Giuliani A; Ravaglia C; Poletti V; Scala R; Guidelli L; Golfi N; Vianello A; Achille A; Lucernoni P; Gaccione AT; Romagnoli M; Fraccaro A; Malacchini N; Malerba M; Ragnoli B; Zamparelli AS; Bocchino M; Blasi F; Spotti M; Miele C; Piedepalumbo F; Barone I; Baglioni S; Dodaj M; Franco C; Andrani F; Mangia A; Mancini A; Carrozzi L; Rafanelli A; Casto E; Rogliani P; Ora J; Carpagnano GE; Di Lecce V; Tamburrini M; Papi A; Contoli M; Luzzati R; Zatta M; Di Bella S; Caraffa E; Francisci D; Tosti A; Pallotto C; De Rosa FG; Pecori A; Franceschini M; Carlin M; Orsini V; Spolti A; Inannace M; Santantonio T; Meli R; Sauro S; Fedeli C; Mangini E; Biolo G; Nunnari A; Pietrangelo A; Corradini E; Bocchi D; Boarini C; Zucchetto A; Lanini S Eur Respir J; 2023 Apr; 61(4):. PubMed ID: 36356972 [TBL] [Abstract][Full Text] [Related]
5. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial. Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241 [TBL] [Abstract][Full Text] [Related]
6. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial. Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739 [TBL] [Abstract][Full Text] [Related]
7. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial. Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A; Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496 [TBL] [Abstract][Full Text] [Related]
8. Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial. Salvarani C; Massari M; Costantini M; Merlo DF; Mariani GL; Viale P; Nava S; Guaraldi G; Dolci G; Boni L; Savoldi L; Bruzzi P; Turrà C; Catanoso M; Marata AM; Barbieri C; Valcavi A; Franzoni F; Cavuto S; Mazzi G; Corsini R; Trapani F; Bartoloni A; Barisione E; Barbieri C; Burastero GJ; Pan A; Inojosa W; Scala R; Burattini C; Luppi F; Codeluppi M; Tarek KE; Cenderello G; Salio M; Foti G; Dongilli R; Bajocchi G; Negri EA; Ciusa G; Fornaro G; Bassi I; Zammarchi L; Aloè T; Facciolongo N Eur Respir J; 2022 Oct; 60(4):. PubMed ID: 35361632 [TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
11. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial. Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638 [TBL] [Abstract][Full Text] [Related]
13. A randomized open-label trial to evaluate the efficacy and safety of triple therapy with aspirin, atorvastatin, and nicorandil in hospitalised patients with SARS Cov-2 infection: A structured summary of a study protocol for a randomized controlled trial. Sharma A; Sharma C; Raina S; Singh B; Dadhwal DS; Dogra V; Gupta S; Bhandari S; Sood V Trials; 2021 Jul; 22(1):451. PubMed ID: 34266452 [TBL] [Abstract][Full Text] [Related]
14. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial. Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098 [TBL] [Abstract][Full Text] [Related]
15. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial. Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effect of intravenous dexamethasone and methylprednisolone on the treatment of hospitalized patients with COVID-19: a randomized clinical trial. Dastenae ZH; Bahadori A; Dehghani M; Asadi-Samani M; Izadi I; Shahraki HR Int J Infect Dis; 2022 Sep; 122():659-664. PubMed ID: 35817286 [TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol. Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R; Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394 [TBL] [Abstract][Full Text] [Related]
19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
20. Letter to the editor: efficacy of different methods of combination regimen administrations including dexamethasone, intravenous immunoglobulin, and interferon-beta to treat critically ill COVID-19 patients: a structured summary of a study protocol for a randomized controlled trial. Abdolahi N; Kaheh E; Golsha R; Khodabakhshi B; Norouzi A; Khandashpoor M; Besharat S; Tavassoli S; Livani S; Azimi SA; Gharib MH; Peivandi B; Fazel A; Shirzad-Aski H; Roshandel G Trials; 2020 Jun; 21(1):549. PubMed ID: 32560745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]